ACHV

Stats

Summary

Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide. and nearly half a million deaths in the U.S. annually.12 More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke. Achieve's focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in smoking cessation by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and by reducing the reward and satisfaction associated with smoking.

Market Cap: 65.9 Million

Primary Exchange: NASDAQ

Website: achievelifesciences.com

Shares Outstanding: 9.45 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.952916721097771

Sector: Manufacturing

Industry: In-Vitro Diagnostic Substance Manufacturing

Ethical Flags

Longest drawdown: 2088 trading days

From: 2014-03-10 To: 2021-12-03

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor
2017-08-03				11.0	1.0	11.0